Awareness of rules of NSAID use in 125 treated patients;Connaissance par 125 patients des regles de prise de leur anti-inflammatoire non steroidien

Therapie

Volumn 54, Issue 6, 1999, Pages 683-688

  Berthelot, J M ^a   Millet, S ^a   Chatelier, B ^a   Ripoll, N ^a   Maugars, Y ^a   Prost, A ^a  

^a HÔTEL DIEU   (France)

Author keywords

Aspirin; Awareness; Compliance; Instructions for use; Leaflet; NSAIDs; Package insert

Indexed keywords

ACETYLSALICYLIC ACID; ARTHROTEC; DICLOFENAC; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; DRUG INFORMATION; DRUG SAFETY; DRUG USE; HUMAN; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUESTIONNAIRE; RHEUMATIC DISEASE; RHEUMATOLOGY;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; DRUG INTERACTIONS; DRUGS, NON-PRESCRIPTION; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENTS; PHYSICIAN-PATIENT RELATIONS; QUESTIONNAIRES; RISK FACTORS; SELF ADMINISTRATION; SELF MEDICATION;

EID: 0033369187     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Somerville K, Faulkner G, Langman M. Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer. Lancet 1986; i: 462-464.
2. Halles J. Drug-related hospital admissions in subspecialities of internal medicine. Dan Med Bull 1996; 43: 141-155.
3. Herxheimer A. Many NSAIDs users who bleed don't know when to stop. Uncomprehending 'adherence' is dangerous. BMJ 1998; 316: 492.
4. Wynne HA, Long A. Patient awareness of the adverse effect of non-steroidal anti-inflammatory drugs (NSAIDs). Br J Clin Pharmacol 1998; 42: 253-256.
5. Altimiras J, Borras JM, Mendez E et al. Knowledge of medication in hospitalized chronic respiratory patients. Pharm Weekbl Sci 1992; 14: 174-179.
6. Montano-Alonso A, Torello-Isente J, Castillo-Fernando JR et al. The knowledge and attitude of consumers in relation to the use of NSAIDs. An intervention study. Aten Primaria 1997; 20: 116-120.
7. Tamblyn R. Medication use in seniors: challenges and solutions. Therapie 1996; 51: 269-282.
8. Cunnigham G, Dodd TR, Grant DJ et al. Drugs related problems in elderly patients admitted to Tayside hospitals; methods for prevention and subsequent reassessment. Age Ageing 1997; 26: 375-382.
9. Gruber W, Llewelyn J, Arras C, Lion S. The role of the pharmaceutical industry in promoting patient education. Patient Educ Cons 1995; 26: 245-249.
10. Bradley B, Mc Cusker E, Scott E, Li-Wan-Po A. Patient information leaflets or over-the-counter medicines: the manufacturers' perspectives. J Clin Pharm Ther 1995; 20; 37-40.
11. Griffin JP, Griffin JR. Informing the patient. J Roy Coll Phys Lond 1996; 30: 107-111.
12. Gibbs S, Waters WE, George CF. Prescription information leaflets: a national survey. J Roy Soc Med 1990; 83: 292-297.
13. Gibbs S, Waters WE, George CF. The benefits of prescription information leaflets. Br J Clin Pharmacol 1989; 27: 723-739.
14. Auriche M, Courtrand M, Danan G et al. Drugs and patient information. Writing of instructions. Therapie 1994; 49: 9-13.
15. Basara LR, Juergens JP. Patient package insert readability and design. Ann Pharm 1994; NS34: 48-53.
16. Vander-Stichele RH, Van Haecht CH, Braem MD, Bogaert MG. Attitude of the public toward technical package inserts for medication information in Belgium. DICP 1991; 25: 1002-1004.
17. Montastruc JL, Bagheri H, Geraud T, Lapeyre-Mestre M. Pharmacovigilance de l'automédication. Therapie 1997; 52: 105-110.
18. Batty GM, Oborne CA, Swift CG, Jackson SM. The use of over-the-counter medication by elderly medical in-patients. Postgrad Med J 1997; 73: 720-722.
19. Marinker M. From compliance to concordance: achieving shared goals in medicine taking. BMJ 1997; 314: 747-748.
20. de Klerk E, van der Linden S. Compliance monitoring of NSAIDs drug-therapy in ankylosing spondylitis, experiences with an electronic monitoring device. Br J Rheumatol 1996; 35: 60-65.
21. Fincke BG, Miller DR, Spiro A III. The interaction of patient perception of overmedication with drugs compliance and side effects. J Gen Intern Med 1998; 13: 182-185.
22. Hasford J, Lamprecht T. Company observational post-marketing studies: drug risk assessment and drug research in special populations. A study-based analysis (letter). Eur J Clin Pharmacol 1998; 53: 369-371.
23. Urquhart J, de Klerk E. Contending paradigms for the interpretation of data on patient compliance with therapeutic drug regimens. Stat Med 1998; 17: 251-267.